This study examines psychological determinants and effects of participating in genetic testing among persons diagnosed with or at risk for developing primary pulmonary arterial hypertension. Longitudinal data were drawn from orally administered surveys with 70 affected or at-risk individuals concerning their thoughts, feelings, and decision making about testing for mutations in BMPR2. Distress was measured by use of the Impact of Events Scale. Variations in tolerance for ambiguity were also examined. Although uptake of testing was low, as is common for incompletely penetrant mutations that lack clear therapeutic interventions, we found that those who participated in testing evidenced greater reduction in distress compared to those who had not participated in testing, irrespective of test result. No differences in tolerance for ambiguity by testing status were found. Participation in genetic testing, irrespective of test results, may be particularly beneficial to individuals who may have genetic mutations and who are experiencing high levels of distress.
Get full access to this article
View all access options for this article.
References
1.
AustinED, LoydJE, PhillipsJA3rd. 2009. Genetics of pulmonary arterial hypertension. Semin Respir Crit Care Med, 30:386-398.
2.
BadeschDB, ChampionHC, SanchezMAet al.2009. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 54:S55-66.
3.
BarnoyS. 2007. Genetic testing for late-onset diseases: effect of disease controllability, test predictivity, and gender on the decision to take the test. Genet Test, 11:187-192.
4.
BatyBJ, DudleyWN, MustersA, KinneyAY. 2006. Uncertainty in BRCA1 cancer susceptibility testing. Am J Med Genet C Semin Med Genet, 142C:241-250.
5.
BaumertJ, SimonH, GundelHet al.2004. The impact of event scale-revised: evaluation of the subscales and correlations to psychophysiological startle response patterns in survivors of a life-threatening cardiac event. J Affect Disord, 82:29-41.
6.
BleikerEM, MenkoFH, KluijtIet al.2007. Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hered Cancer Clin Pract, 5:59-66.
7.
BroadstockM, MichieS, MarteauT. 2000. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet, 8:731-738.
8.
ChanA, ChanYH. 2004. Psychological impact of the 2003 severe acute respiratory syndrome outbreak on health care workers in a medium size regional general hospital in Singapore. Occup Med, 54:190-196.
9.
ClaesE, DenayerL, Evers-KieboomsGet al.2005. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test, 9:54-65.
10.
CodoriAM, PetersenGM, MigliorettiDLet al.1999. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev, 8:345-351.
11.
DicksonMR, CarterCL, CarpenterMJet al.2008. Barriers to genetic testing among persons at risk for alpha-1 antitrypsin deficiency. Genet Test, 12:501-505.
12.
DorvalM, BouchardK, MaunsellEet al.2008. Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population. J Genet Couns, 17:314-326.
13.
DougallAL, CraigK, BaumA. 1999. Assessment of characteristics of intrusive thoughts and their impact on distress among victims of traumatic events. Psychosom Med, 61:38-48.
14.
FosterC, EvansDG, EelesRet al.2004. Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genet Test, 8:23-29.
15.
GargiuloM, LejeuneS, TanguyMLet al.2009. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet, 17:165-171.
16.
GellerG, TamborES, ChaseGA, HoltzmanNA. 1993. Measuring physicians' tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Med Care, 31:989-1001.
17.
GoodingHC, LinnenbringerEL, BurackJet al.2006. Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk. Patient Educ Couns, 64:259-267.
18.
GritzER, PetersonSK, VernonSWet al.2005. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol, 23:1902-1910.
19.
HadleyDW, JenkinsJ, DimondEet al.2003. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med, 163:573-582.
20.
HalbertCH, WenzelL, LermanCet al.2004. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev, 13:875-881.
21.
HannigVL, WheelerL, PhillipsJAIIIet al.2008. Interest in clinical genetic testing for familial pulmonary arterial hypertension (FPAH)Paper presented at American Thoracic Society.
22.
HirakiS, ChenCA, RobertsJSet al.2009. Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease. J Genet Couns, 18:130-136.
23.
HorowitzM, WilnerN, AlvarezW. 1979. Impact of event scale: a measure of subjective stress. Psychosom Med, 41:209-218.
24.
JonesDL, SandbergJC, RosenthalMJet al.2008. What patients and their relatives think about testing for BMPR2. J Genet Couns, 17:452-458.
25.
KellerM, JostR, KadmonMet al.2004. Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling. Dis Colon Rectum, 47:153-162.
26.
LermanC, CroyleRT. 1996. Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology, 10:191-195.
27.
LermanC, HughesC, TrockBJet al.1999. Genetic testing in families with hereditary nonpolyposis colon cancer. Jama, 281:1618-1622.
28.
LermanC, SchwartzMD, LinTHet al.1997. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol, 65:414-420.
29.
LewisJR, KondaV, RubinDT. 2009. Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members. Genet Test Mol Biomarkers, 13:495-503.
30.
LickledererC, WolffG, BarthJ. 2008. Mental health and quality of life after genetic testing for Huntington disease: a long-term effect study in Germany. Am J Med Genet A, 146A:2078-2085.
31.
LientzEA, ClaytonEW. 2000. Psychosocial implications of primary pulmonary hypertension. Am J Hum Genet, 59,suppl 2:209.
32.
MetcalfeA, WerrettJ, BurgessL, CliffordC. 2007. Psychosocial impact of the lack of information given at referral about familial risk for cancer. Psycho-oncology, 16:458-465.
33.
PatchC, RoderickP, RosenbergW. 2005. Comparison of genotypic and phenotypic strategies for population screening in hemochromatosis: assessment of anxiety, depression, and perception of health. Genet Med, 7:550-556.
34.
RopkaME, WenzelJ, PhillipsEKet al.2006. Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev, 15:840-855.
35.
SchwartzMD, PeshkinBN, HughesCet al.2002. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol, 20:514-520.
36.
ShilohS, IlanS. 2005. To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing. J Behav Med, 28:467-479.
37.
SmithCO, LipeHP, BirdTD. 2004. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol, 61:875-880.
38.
TaylorSD. 2005. Predictive genetic test decisions for Huntington's disease: elucidating the test/no-test dichotomy. J Health Psychol, 10:597-612.
39.
TercyakKP, LermanC, PeshkinBNet al.2001. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol, 20:217-222.
40.
ThompsonHS, ValdimarsdottirHB, Duteau-BuckCet al.2002. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev, 11:1579-1585.
41.
van RoosmalenMS, StalmeierPF, VerhoefLCet al.2004. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet A, 124A:346-355.
42.
WeissS. 2004. Assessing Psychological Trauma and PTSD. Guilford Press: New York.
